Communications in Information and Systems最新文献

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have compromised existing vaccines and posed a grand challenge to coronavirus disease 2019 (COVID-19) prevention, control, and global economic recovery. For COVID-19 patients, one of the most effective COVID-19 medications is monoclonal antibody (mAb) therapies. The United States Food and Drug Administration (U.S. FDA) has given the emergency use authorization (EUA) to a few mAbs, including those from Regeneron, Eli Elly, etc. However, they are also undermined by SARS-CoV-2 mutations. It is imperative to develop effective mutation-proof mAbs for treating COVID-19 patients infected by all emerging variants and/or the original SARS-CoV-2. We carry out a deep mutational scanning to present the blueprint of such mAbs using algebraic topology and artificial intelligence (AI). To reduce the risk of clinical trial-related failure, we select five mAbs either with FDA EUA or in clinical trials as our starting point. We demonstrate that topological AI-designed mAbs are effective for variants of concerns and variants of interest designated by the World Health Organization (WHO), as well as the original SARS-CoV-2. Our topological AI methodologies have been validated by tens of thousands of deep mutational data and their predictions have been confirmed by results from tens of experimental laboratories and population-level statistics of genome isolates from hundreds of thousands of patients.

A carbohydrate, also called saccharide in biochemistry, is a biomolecule consisting of carbon (C), hydrogen (H) and oxygen (O) atoms. For example, sugars are low molecular-weight carbohydrates, and starches are high molecular-weight carbohydrates. Carbohydrates are the most abundant organic substances in nature and essential constituents of all living things. Protein-carbohydrate interactions play important roles in many biological processes, such as cell growth, differentiation, and aggregation. They also have broad applications in pharmaceutical drug design. In this review, we will summarize the characteristic features of protein-carbohydrate interactions and review the computational methods for structure prediction, energy calculations, and kinetic studies of protein-carbohydrate complexes. Finally, we will discuss the challenges in this field.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by coronavirus disease 2019 (COVID-19) has led to a tremendous human fatality and economic loss. SARS-CoV-2 infectivity is a key reason for the widespread viral transmission, but its rigorous experimental measurement is essentially impossible due to the ongoing genome evolution around the world. We show that artificial intelligence (AI) and algebraic topology (AT) offer an accurate and efficient alternative to the experimental determination of viral infectivity. AI and AT analysis indicates that the on-going mutations make SARS-CoV-2 more infectious.

Because of their potential utility in predicting conformational changes and assessing folding dynamics, coarse-grained (CG) RNA folding models are appealing for rapid characterization of RNA molecules. Previously, we reported the iterative simulated RNA reference state (IsRNA) method for parameterizing a CG force field for RNA folding, which consecutively updates the simulation force field to reflect marginal distributions of folding coordinates in the structure database and extract various energy terms. While the IsRNA model was validated by showing close agreement between the IsRNA-simulated and experimentally observed distributions, here, we expand our theoretical understanding of the model and, in doing so, improve the parameterization process to optimize the subset of included folding coordinates, which leads to accelerated simulations. Using statistical mechanical theory, we analyze the underlying, Bayesian concept that drives parameterization of the energy function, providing a general method for developing predictive, knowledge-based, polymer force fields on the basis of limited data. Furthermore, we propose an optimal parameterization procedure, based on the principal of maximum entropy.

Protein-RNA interaction is among the most essential of biological events in living cells, being involved in protein synthesizing, RNA processing and transport, DNA transcription, and regulation of gene expression, and many other critical bio-molecular activities. A thorough understanding of this interaction is of paramount importance in fundamental study of a variety of vital cellular processes and therapeutic application for remedy of a broad range of diseases. Experimental high-resolution 3D structure determination is the primary source of knowledge for protein-RNA complexes. However, due to technical limitations, the existing techniques for experimental structure determination couldn't match the demand from fast growing interest in academia and industry. This problem necessitates the alternative high-throughput computational method for protein-RNA complex structure prediction. Similar to the in silico methods used for protein-protein and protein-DNA interactions, a reliable prediction of protein-RNA complex structure requires a scoring function with commensurate discriminatory power. Derived from determined structures and purposed to predict the to-be-determined structures, the scoring function is not only a predictive tool but also a gauge of our knowledge of protein-RNA interaction. In this review, we present an overview of the status of existing scoring functions and the scientific principle behind their constructions as well as their strengths and limitations. Finally, we will discuss about future directions of the scoring function development for protein-RNA structure prediction.

It remains a challenging task to generate a vast variety of novel compounds with desirable pharmacological properties. In this work, a generative network complex (GNC) is proposed as a new platform for designing novel compounds, predicting their physical and chemical properties, and selecting potential drug candidates that fulfill various druggable criteria such as binding affinity, solubility, partition coefficient, etc. We combine a SMILES string generator, which consists of an encoder, a drug-property controlled or regulated latent space, and a decoder, with verification deep neural networks, a target-specific three-dimensional (3D) pose generator, and mathematical deep learning networks to generate new compounds, predict their drug properties, construct 3D poses associated with target proteins, and reevaluate druggability, respectively. New compounds were generated in the latent space by either randomized output, controlled output, or optimized output. In our demonstration, 2.08 million and 2.8 million novel compounds are generated respectively for Cathepsin S and BACE targets. These new compounds are very different from the seeds and cover a larger chemical space. For potentially active compounds, their 3D poses are generated using a state-of-the-art method. The resulting 3D complexes are further evaluated for druggability by a championing deep learning algorithm based on algebraic topology, differential geometry, and algebraic graph theories. Performed on supercomputers, the whole process took less than one week. Therefore, our GNC is an efficient new paradigm for discovering new drug candidates.

Coagulation and fragmentation (CF) is a fundamental process in which smaller particles attach to each other to form larger clusters while existing clusters break up into smaller particles . It is a ubiquitous process that plays important roles in many physical and biological phenomena. CF is typically a stochastic process that often occurs in confined spaces with a limited number of available particles . Here, we study the CF process formulated with the discrete Chemical Master Equation (dCME). Using the newly developed Accurate Chemical Master Equation (ACME) method, we examine the time-dependent behavior of the CF system. We investigate the effects of a number of important factors that influence the overall behavior of the system, including the dimensionality, the ratio of attachment to detachment rates among clusters, and the initial conditions. By comparing CF in one and three dimensions, we conclude that systems in three dimensions are more likely to form large clusters. We also demonstrate how the ratio of the attachment to detachment rates affects the dynamics and the steady-state of the system. Finally, we demonstrate the relationship between the formation of large clusters and the initial condition.

Hemostasis and thrombosis are often thought as two sides of the same clotting mechanism whereas hemostasis is a natural protective mechanism to prevent bleeding and thrombosis is a blood clot abnormally formulated inside a blood vessel, blocking the normal blood flow. The evidence to date suggests that at least arterial thrombosis results from the same critical pathways of hemostasis. Analysis of these complex processes and pathways using quantitative systems pharmacological model-based approach can facilitate the delineation of the causal pathways that lead to the emergence of thrombosis. In this paper, we provide an overview of the main molecular and physiological mechanisms associated with hemostasis and thrombosis, and review the models and quantitative system pharmacological modeling approaches that are relevant in characterizing the interplay among the multiple factors and pathways of thrombosis. An emphasis is given to computational models for drug development. Future trends are discussed.